Flanking p10 contribution and sequence bias in matrix based epitope prediction: Revisiting the assumption of independent binding pockets

BMC Structural Biology

Volumn 8, Issue , 2008, Pages

  Parry, Christian S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LEUKOCYTE ANTIGEN; PEPTIDE LIBRARY; PROTEIN P10; HLA DR1 ANTIGEN; INTEGRIN;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CANONICAL ANALYSIS; DNA FLANKING REGION; MEASUREMENT; QUANTITATIVE STUDY; T LYMPHOCYTE; BINDING SITE; BIOLOGY; CHEMISTRY; GENETIC POLYMORPHISM; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; BINDING SITES; COMPUTATIONAL BIOLOGY; EPITOPES; HLA-DR1 ANTIGEN; HUMANS; INTEGRINS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; POLYMORPHISM, GENETIC;

EID: 57649128381     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-8-44     Document Type: Article

References (42)

1. Antigen processing by the proteasome. PM Kloetzel, Nat Rev Mol Cell Biol 2001 2 179 187 10.1038/35056572 11265247
2. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. C Watts, Nat Immunol 2004 5 685 692 10.1038/ni1088 15224094
3. Genomic structure and function in the MHC. J Trowsdale, Trends Genet 1993 9 117 122 10.1016/0168-9525(93)90205-V 8516845
4. Structure of the human class I histocompatibility antigen, HLA-A2. PJ Bjorkman MA Saper B Samraoui WS Bennett JL Strominger DC Wiley, Nature 1987 329 506 512 10.1038/329506a0 3309677
5. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. PJ Bjorkman MA Saper B Samraoui WS Bennett JL Strominger DC Wiley, Nature 1987 329 512 518 10.1038/329512a0 2443855
6. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. TP Garrett MA Saper PJ Bjorkman JL Strominger DC Wiley, Nature 1989 342 692 696 10.1038/342692a0 2594067
7. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. RM Zinkernagel PC Doherty, Nature 1974 248 701 702 10.1038/248701a0 4133807
8. The three-dimensional structure of peptide-MHC complexes. DR Madden, Annu Rev Immunol 1995 13 587 622 10.1146/annurev.iy.13.040195.003103 7612235
9. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. TS Jardetzky JH Brown JC Gorga LJ Stern RG Urban JL Strominger DC Wiley, Proc Natl Acad Sci USA 1996 93 734 738 8570625 10.1073/pnas.93.2.734
10. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. S Buus A Sette SM Colon C Miles HM Grey, Science 1987 235 1353 1358 10.1126/science.2435001 2435001
11. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. A Sette S Buus S Colon JA Smith C Miles HM Grey, Nature 1987 328 395 399 10.1038/328395a0 3497349
12. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Hammer B Takacs F Sinigaglia, J Exp Med 1992 176 1007 1013 1402647 10.1084/jem.176.4.1007
13. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. G Malcherek V Gnau G Jung HG Rammensee A Melms, J Exp Med 1995 181 527 536 7836909 10.1084/jem.181.2.527
14. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. A Sette S Buus E Appella JA Smith R Chesnut C Miles SM Colon HM Grey, Proc Natl Acad Sci USA 1989 86 3296 3300 2717617 10.1073/pnas.86.9.3296
15. Exact prediction of a natural T cell epitope. O Rotzschke K Falk S Stevanovic G Jung P Walden HG Rammensee, Eur J Immunol 1991 21 2891 2894 10.1002/eji.1830211136 1718764
16. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. KC Parker MA Bednarek JE Coligan, J Immunol 1994 152 163 175 8254189
17. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Hammer E Bono F Gallazzi C Belunis Z Nagy F Sinigaglia, J Exp Med 1994 180 2353 2358 7964508 10.1084/jem.180.6.2353
18. Several common HLA-DR types share largely overlapping peptide binding repertoires. S Southwood J Sidney A Kondo MF del Guercio E Appella S Hoffman RT Kubo RW Chesnut HM Grey A Sette, J Immunol 1998 160 3363 3373 9531296
19. SYFPEITHI: database for MHC ligands and peptide motifs. H Rammensee J Bachmann NP Emmerich OA Bachor S Stevanovic, Immunogenetics 1999 50 213 219 10.1007/s002510050595 10602881
20. Cutting edge: identification of novel T cell epitopes in Lol p5a by computational prediction. C de Lalla T Sturniolo L Abbruzzese J Hammer A Sidoli F Sinigaglia P Panina-Bordignon, J Immunol 1999 163 1725 1729 10438899
21. Identification of a promiscuous T-cell epitope in Mycobacterium tuberculosis Mce proteins. M Panigada T Sturniolo G Besozzi MG Boccieri F Sinigaglia GG Grassi F Grassi, Infect Immun 2002 70 79 85 11748166 10.1128/IAI.70.1.79-85.2002
22. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells. R Schroers XF Huang J Hammer J Zhang SY Chen, Cancer Res 2002 62 2600 2605 11980655
23. Immunoinformatics comes of age. B Korber M LaBute K Yusim, PLoS Comput Biol 2006 2 e71 16846250 10.1371/journal.pcbi.0020071
24. Prediction of T-cell epitope. H Tsurui T Takahashi, J Pharmacol Sci 2007 105 299 316 10.1254/jphs.CR0070056 18094522
25. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively. K Bartnes F Leon JP Briand PJ Travers K Hannestad, Eur J Immunol 1999 29 189 195 10.1002/(SICI)1521-4141(199901)29:01<189::AID-IMMU189>3.0.CO;2-X 9933100
26. Immunoreactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in "autoimmunity.". NR Shulman RH Aster A Leitner MC Hiller, J Clin Invest 1961 40 1597 1620 16695867 10.1172/JCI104383
27. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. PJ Newman RS Derbes RH Aster, J Clin Invest 1989 83 1778 1781 2565345 10.1172/JCI114082
28. Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity. CS Parry J Gorski LJ Stern, J Mol Biol 2007 371 435 446 10.1016/j.jmb.2007.05. 025 17583734
29. C-terminal anchoring of a peptide to class II MHC via the P10 residue is compatible with a peptide bulge. M Yassai A Afsari J Garlie J Gorski, J Immunol 2002 168 1281 1285 11801666
30. Truncation analysis of several DR binding epitopes. D O'Sullivan J Sidney MF Del Guercio SM Colon A Sette, J Immunol 1991 146 1240 1246 1704034
31. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. Z Zavala-Ruiz I Strug MW Anderson J Gorski LJ Stern, Chem Biol 2004 11 1395 1402 10.1016/j.chembiol.2004.08.007 15489166
32. HLA-DR binding analysis of peptides from islet antigens in IDDM. A Geluk KE van Meijgaarden NC Schloot JW Drijfhout TH Ottenhoff BO Roep, Diabetes 1998 47 1594 1601 10.2337/diabetes.47.10.1594 9753297
33. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. T Sturniolo E Bono J Ding L Raddrizzani O Tuereci U Sahin, Nat Biotechnol 1999 17 555 561 10.1038/9858 10385319
34. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. HH Bui J Sidney B Peters M Sathiamurthy A Sinichi KA Purton BR Mothe FV Chisari DI Watkins A Sette, Immunogenetics 2005 57 304 314 10.1007/s00251-005-0798-y 15868141
35. Influence of proline residues on protein conformation. MW MacArthur JM Thornton, J Mol Biol 1991 218 397 412 10.1016/0022-2836(91)90721-H 2010917
36. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein. BJ McFarland JF Katz AJ Sant C Beeson, J Mol Biol 2005 350 170 183 10.1016/j.jmb.2005.04.069 15921691
37. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. BJ McFarland C Beeson AJ Sant, J Immunol 1999 163 3567 3571 10490947
38. Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange. AJ Sant C Beeson B McFarland J Cao S Ceman PW Bryant S Wu, Immunol Rev 1999 172 239 253 10.1111/j.1600-065X.1999.tb01369.x 10631950
39. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. A Pashine R Busch MP Belmares JN Munning RC Doebele M Buckingham GP Nolan ED Mellins, Immunity 2003 19 183 192 10.1016/S1074-7613(03)00200-0 12932352
40. Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. B Peters W Tong J Sidney A Sette Z Weng, Bioinformatics 2003 19 1765 1772 10.1093/bioinformatics/btg247 14512347
41. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. Y Li H Li R Martin RA Mariuzza, J Mol Biol 2000 304 177 188 10.1006/jmbi.2000.4198 11080454
42. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. CA Scott PA Peterson L Teyton IA Wilson, Immunity 1998 8 319 329 10.1016/S1074-7613(00)80537-3 9529149